Catherine Lei

Catherine Lei, Ph.D., is an accomplished professional in health policy and economics, currently serving as the Associate Director of Strategic Pricing and Access at Gilead Sciences since October 2021, following a role as Senior Manager in the same department. In addition to this position, Catherine holds a seat on the Advisory Board of Lighthouse Guild and previously worked as a Strategy Insights and Planning Associate Consultant at ZS, managing client engagements for leading biopharma companies. Academic background includes a Ph.D. from Stanford University School of Medicine, where research focused on drug pricing and regulatory impacts, and a B.A. from Princeton University. Additional experience encompasses consulting roles and research assistant positions at prestigious organizations, showcasing expertise in market strategy, data analysis, and healthcare policy.